The Structure of Recombinant Human IGF2BP2
Recombinant Human IGF2BP2, also known as Insulin-like Growth Factor 2 mRNA-binding protein 2, is a protein that is produced through genetic engineering techniques. It is a 68 kDa protein with a molecular formula of C3H4NO2 and a total of 580 amino acids. The protein is composed of several domains, including two RNA recognition motifs (RRMs) and four K homology (KH) domains. These domains are responsible for the binding of the protein to RNA and are essential for its function.
The structure of Recombinant Human IGF2BP2 is highly conserved among different species, indicating its importance in cellular processes. It has been found to be present in all tissues and cell types, with the highest expression levels in the brain, heart, and pancreas. The protein is known to have a cytoplasmic localization, where it interacts with various RNA molecules and regulates their translation and stability.
The Activity of Recombinant Human IGF2BP2
Recombinant Human IGF2BP2 plays a crucial role in post-transcriptional regulation of gene expression. It binds to specific RNA sequences, mainly those containing the AU-rich elements (AREs), and regulates their translation and stability. By doing so, it controls the expression of various genes involved in cell growth, differentiation, and survival.
One of the key functions of Recombinant Human IGF2BP2 is its role in insulin-like growth factor 2 (IGF2) signaling pathway. The protein binds to and stabilizes IGF2 mRNA, thereby increasing its translation and promoting cell proliferation and survival. It has also been found to regulate the expression of several other growth factors, including vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).
Moreover, Recombinant Human IGF2BP2 has been shown to interact with microRNAs (miRNAs) and regulate their function. MiRNAs are small non-coding RNAs that play a crucial role in gene expression by binding to specific mRNA sequences and inhibiting their translation. By interacting with miRNAs, Recombinant Human IGF2BP2 can modulate their activity and affect the expression of their target genes.
Applications of Recombinant Human IGF2BP2
Given its critical role in gene expression regulation, Recombinant Human IGF2BP2 has been implicated in various diseases and has potential applications in diagnostics and therapeutics. For instance, dysregulation of IGF2BP2 has been linked to cancer progression, and the protein has been proposed as a potential biomarker for cancer diagnosis and prognosis.
Furthermore, Recombinant Human IGF2BP2 has been found to be essential for the growth and survival of pancreatic beta cells, which are responsible for insulin production. Therefore, the protein has been suggested as a potential therapeutic target for type 2 diabetes, where beta cell dysfunction is a key factor.
In addition, Recombinant Human IGF2BP2 has been shown to play a role in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. It has been found to regulate the translation of amyloid precursor protein (APP), which is involved in the formation of amyloid plaques in the brain, a hallmark of Alzheimer’s disease. Therefore, targeting Recombinant Human IGF2BP2 could potentially be a therapeutic strategy for these diseases.
In conclusion, Recombinant Human IGF2BP2 is a crucial protein involved in post-transcriptional regulation of gene expression. Its structure, activity, and applications have been extensively studied, and it has been implicated in various diseases. Further research on this protein may lead to the development of novel diagnostic and therapeutic approaches for these diseases.
There are no reviews yet.